Kiora Pharmaceuticals, Inc. Made Big Gain

Tue, Jun 03, 2025 at 07:49 PM

Kiora Pharmaceuticals, Inc. (KPRX:NASDAQ) jumped higher at $3.9, representing a gain of 36.8%. On Tue, Jun 03, 2025, KPRX:NASDAQ touched a New 2-Week High of $3.9. The stock got featured on our News Catalysts scanner on Tue, Jun 03, 2025 at 09:33 AM in the 'BIOTECH' category. From Tue, May 20, 2025, the stock recorded 22.22% Up Days and 10.00% Green Days

About Kiora Pharmaceuticals, Inc. (KPRX:NASDAQ)

Kiora Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company. It focuses on developing and commercializing products for treating diseases and disorders of the eye.

Top 10 Gainers:

Ctrl Group Limited (MCTR:NASDAQ), 571.44%
Smart for Life, Inc. (SMFL:NASDAQ), 300%
NewGenIvf Group Limited (NIVF:NASDAQ), 115.12%
Latch, Inc. (LTCH:NASDAQ), 75%
Biomea Fusion, Inc. (BMEA:NASDAQ), 60.65%
NuCana plc (NCNA:NASDAQ), 57.37%
Classover Holdings, Inc. (KIDZ:NASDAQ), 46.24%
I-Mab (IMAB:NASDAQ), 46.09%
Kiora Pharmaceuticals, Inc. (KPRX:NASDAQ), 36.84%
Lyra Therapeutics, Inc. (LYRA:NASDAQ), 36.2%